Cargando…
The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-B
Colorectal cancer has risen to the third occurring cancer in the world. Fluorouracil (5-Fu), oxaliplatin, and cisplatin are the most effective chemotherapeutic agents for clinical chemotherapy. Nevertheless, due to chemotherapeutic drug resistance, the survival rate of patients with CRC remains very...
Autores principales: | Wang, Lixue, Chen, Jinlong, Chen, Qijun, Song, Hui, Wang, Ziqian, Xing, Wen, Jin, Siyao, Song, Xueying, Yang, Hua, Zhao, Wenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908333/ https://www.ncbi.nlm.nih.gov/pubmed/36778211 http://dx.doi.org/10.1155/2023/6480848 |
Ejemplares similares
-
Analysis of Intestinal Metabolites in SR−B1 Knockout Mice via Ultra−Performance Liquid Chromatography Quadrupole Time−of−Flight Mass Spectrometry
por: Chen, Qijun, et al.
Publicado: (2023) -
Urolithins: The Colon Microbiota Metabolites as Endocrine Modulators: Prospects and Perspectives
por: Vini, Ravindran, et al.
Publicado: (2022) -
The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs
por: Abdelazeem, Khalid N. M., et al.
Publicado: (2021) -
Urolithin B, a Gut Microbiota Metabolite, Reduced Susceptibility to Myocardial Arrhythmic Predisposition after Hypoxia
por: Huang, Xin, et al.
Publicado: (2022) -
Potential of the ellagic acid-derived gut microbiota metabolite – Urolithin A in gastrointestinal protection
por: Kujawska, Małgorzata, et al.
Publicado: (2020)